YOUR SEARCH FOR Text 165 RESULTS
41 of Total
Supplement to Consumer Health Data Privacy Policy for Nevada Consumers | Incyte.com
… Supplement to Consumer Health Data Privacy Policy for Nevada Consumers This … Privacy Policy for Nevada Consumers | Incyte.com …
42 of Total
Incyte Involved: Unwavering Community Commitment | Incyte Stories
… May 22, 2025 Incyte Involved: Unwavering Community Commitment …
43 of Total
Incyte in 2026 and Beyond | Incyte Stories
… as we accelerate our pipeline and position the company for sustained growth. By year-end, we … and a clear strategy for long-term growth. Bill Meury, President and Chief Executive Officer …
44 of Total
Incyte's Comprehensive Compliance Program - State of California
… … Incyte's Comprehensive Compliance Program - State of California …
45 of Total
Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
… rituximab and lenalidomide, respectively – Bill Meury appointed as President and Chief Executive … June 26, 2025 , upon the retirement of Hervé Hoppenot Conference Call and Webcast Scheduled …
46 of Total
Incyte to Present at Upcoming Investor Conferences | Incyte
… View all news Incyte to Present at Upcoming …
47 of Total
Incyte Announces Executive Leadership Appointments | Incyte
… its executive leadership team to support the Company’s strategic focus and long-term growth … continue to bring to the company,” said Bill Meury , Chief Executive Officer, Incyte . …
48 of Total
Our Commitment to Solve On. Fosters an Award-Winning Culture | Incyte Stories
… December 6, 2023 Our Commitment to Solve On . Fosters an Award-Winning …
49 of Total
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalido
… View all news Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for …
50 of Total
Incyte to Present at Upcoming Investor Conferences
… … Incyte to Present at Upcoming Investor Conferences …